Federal Supply Schedule 36F79720D0230
Award Date
9/15/20
Last Date to Order
9/14/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Medexus Pharma Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Medunik USA Inc., provides a multiple-award vehicle for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $342,000.00 and a period of performance through January 1, 2026. As a Federal Supply Schedule contract, it allows federal agencies to issue task orders against the pre-negotiated terms and...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs to Exela Pharma Sciences LLC, provides a mechanism for the VA's Veterans Integrated Service Network 12 to efficiently procure a wide range of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract has a ceiling value of $20,304,570.00 and a period of performance from September 29, 2024, to September 28, 2029. Exela Pharma Sciences, a minority-owned, self-certified small...
This Federal Supply Schedule contract, awarded to Mylan Specialty LP by the Department of Veterans Affairs Veterans Health Administration, has a potential value of over $514 million and runs through January 2027. The contract provides for the procurement of pharmaceuticals, drugs, hematology products, and related medical supplies to serve the healthcare needs of veterans. As a multiple award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule, this agreement enables...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Medicure Pharma Inc. The contract ID is 36F79723D0236 and has a ceiling value of $7,454,790.00. The contract is for the procurement of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" and has an ultimate completion date of September 28, 2028. Medicure Pharma Inc., a for-profit manufacturer of goods, was awarded this multiple-award FSS...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to H2-Pharma LLC, a for-profit limited liability company. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The contract is for 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. This indicates the contract is focused on...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...
The contract is a Federal Supply Schedule (FSS) award to Mayne Pharma Commercial LLC, a foreign-owned, for-profit manufacturer of goods. The contract is for pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a contract ceiling value of $53,029,735.90 and a period of performance from July 15, 2025 to July 14, 2030. The contracting agency is the Veterans Integrated Service Network 12, a civilian federal agency. The contract does not have any set-asides and was awarded...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...